Granulocyte function in burn injury has been evaluated with an in vitro animal assay. Bactericidal activity, using this technique, was markedly depressed only when granulocytes from scald burned rats were challenged with each of three strains ofPseudomonas aeruginosa in the presence of autologous postburn serum or heat-inactivated serum. Preincubation of postburn and normal serum at 37°C for 1 h resulted in normal phagocytosis. These studies validate an investigation of plasma and/or granulocyte replacement therapy in the burned patient.
Infection with Pseudomonas aeruginosa remains the major cause of death in burn patients. Attempts to eliminate such infection with the use of topical antibacterial therapy and systemic antibiotics have been only minimally effective and point to the necessity of a better understanding of the burn patient's host defense. Although alterations in humoral immune defense mechanisms have been cited (2, 8, 15, 16) , the experimental and clinical use of immune vaccines and passive immunization with pseudomonas antibody have not altered mortality in this disease state. Impaired granulocyte function (3), granulocytopenia (17) , and altered serum opsonic activity (4) have all been implicated as crucial defects in host defense in the presence of a pseudomonas infection.
Recently, we have quantitated the relationship between normal granulocyte function and mortality in an infected, burned rat model by using three distinct strains of P. aeruginosa (14) . Using similar techniques, we have now measured in vitro bactericidal activity in these same organisms by granulocytes from scald burned rats. Additionally, attempts were made to distinguish between cellular and serum-mediated abnormalities, since such data have significant bearing upon the efficacy of granulocyte replacement therapy.
MATERIALS AND METHODS
In vitro granulocyte bactericidal activity upon three strains of P. aeruginosa was measured after infliction of a 30% third-degree scald burn (21 tality rates in the scald burned rat.) At 4 h and 1, 2, 3, 5, and 10 days postburn, intraperitoneal granulocytes were collected by a modification of the method of Hirsch (13) . Cells were adjusted to a final concentration of 5 x 106/ml. Three strains ofP. aeruginosa, subcultured and stored at -70°C, were each seeded in Trypticase soy broth at 37°C. After 18 h of growth, final bacterial concentrations of 5 x 106, 109, and 1010 bacteria/ml ofculture were prepared for strains I, II, and III, respectively. Such concentrations, when incubated with 5 x 106 granulocytes from normal unburned controls, resulted in 90% bactericidal activity, Assays were performed as a modification of the technique of Sbarra et al. (19) . Experimental tubes included granulocytes, bacteria, autologous serum (40%), and Krebs-Ringer phosphate medium. Control tubes were similarly constituted without leukocytes. After a 90-min incubation, samples of both control and experimental reactions were removed, serially diluted, and plated in Trypticase soy agar. After incubation at 37°C for 24 h, bacterial colonies were counted and corrected for dilutions, and comparisons were made between control and experimental groups.
RESULTS
Leukocyte recovery from animals after bum injury was markedly diminished when compared to control animals (Table 1) and remained low even at 10 days postbum. Differential cell counts of peritoneal exudates are included for both control and 2-day postburn animals and indicate that, whereas total yields were markedly decreased, mature, granulocyte, eosinophil, lymphocyte, and monocyte components of the cell compartment remained constant. When peritoneal granulocytes collected from postbum animals were challenged by each of the three strains ofP. aeruginosa, a marked depression in bactericidal activity was observed at all time periods (Fig. 1) .
In an attempt to isolate an inhibitor or a SERUM deficiency causing this decrease in bactericidal activity, we performed the experiments shown CELLS in Fig (18), Chediak-Higashi syndrome (10) , and myeloproliferative disorders (11) . Moreover, patients with diabetes mellitus (6) and lymphoproliferative diseases (19) have demonstrated depressed granulocyte phagocytosis.
P. aeruginosa has low invasiveness in healthy individuals but can cause sepsis in patients who have serious underlying diseases. The increased incidence of pseudomonas infection in acute leukemia has been correlated with absolute granulocytopenia (20) . We have previously reported (7) early depletion of bone marrow granulocyte stores in scald burned rats and concomitant depletion ofthe marginating granulocyte compartment. This absolute granulocytopenia was magnified in the presence of an experimental pseudomonas infection of the burn wound (17) . Whereas pseudomonas is not invasive in the normal rat, it is lethal in the scald burned animal. Recent investigations with three strains of Pseudomonas correlate the mortality produced by infection with resistance to bactericidal activity by normal granulocytes (14) . We suggest that suppression of host defense in burns may also be directly related to granulocyte and serum abnormalities.
The current studies demonstrate depressed bactericidal activity by postburn granulocytes in the presence ofautologous postburn serum or heat-labile normal serum. It would appear that granulocytes from bumed animals lack an essential factor(s) for the phagocytosis of P. aeruginosa and that this defect can be corrected by incubation with normal serum but not by incubation with autologous postburn serum. The necessary factor(s) in normal serum is heat labile. Studies were not performed to identify this material(s) or to determine whether an identical defect is present on bum cells. However, these studies are worthy of consideration. It may be, for example, that a number ofdefects in bum cells and burn serum may exist and that normal cells phagocytose in the presence of bum serum because such cells have been exposed to this material in vivo. Since neither burned nor normal granulocytes were capable of phagocytosis of pseudomonas in the absence of either serum, it is clear that other serum factors must play a role in this process. In the absence of granulocytes, bacterial cell growth measured by colony counts was constant in the GRANULOCYTES AND PSEUDOMONAS 401 presence of either buffer or normal, burned, or attenuated serum. Alexander (1) has reported both a deficiency in lysosomal enzymes and decreased intracellular killing of bacteria by granulocytes from burned patients in the presence of normal pooled serum. We were unable to identify a suppression in bactericidal activity in granulocytes from burned animals unless these cells were incubated in autologous postburn serum.
The importance of reactions between granulocytes and serum factors that result in chemotaxis, phagocytosis, and degranulation has been established (5, 12) . Recovery of peritoneal granulocytes by casein infusion was markedly reduced in our animals after burn injury. Whereas this could be explained by postburn granulocytopenia (7), it might also be a reflection of altered chemotaxis. Warden et al. (22) have recently demonstrated decreased leukocyte migration in granulocytes from 50 burned patients, using casein as a stimulus.
Bjornson and Alexander (4) have reported reduced opsonic activity in the sera of burned patients. This defect could be corrected by mixing burned sera with normal sera but reappeared when the two sera were preincubated. In our studies, no inhibitor could be demonstrated either when burned serum was mixed with normal serum or when burned serum was preincubated with normal serum for 1 h. These in vitro studies demonstrate abnormalities in bactericidal activity that occur only in the coincubation ofpostburn granulocytes and postburn or heat-treated serum. Fjellstrom and Arturson (9) , and Bjornson and Alexander (4) have demonstrated marked suppression of functional complement activity in the sera of burned patients. These observations coincide with serum defect(s) that we have described. We believe these data justify an investigation of the feasibility and efficacy ofplasma and/or granulocyte replacement therapy in the burned subject to reduce the incidence and morbidity ofpseudomonas infections. 
